PR interval and the response to enzyme-replacement therapy for Fabry's disease

被引：34
|
作者：
Waldek, S [1 ]
机构：
[1] Hope Hosp, Manchester M6 8HD, Lancs, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 12期
关键词：
D O I：
10.1056/NEJM200303203481224
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1186 / 1187
页数：2
相关论文
共 50 条
  • [41] Fabry disease in children and response to enzyme replacement therapy: results from the fabry outcome survey
    Ramaswami, U.
    Parini, R.
    Pintos-Morell, G.
    Hartung, R.
    Kampmann, C.
    Beck, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 122 - 122
  • [42] Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey
    Ramaswami, U.
    Parini, R.
    Pintos-Morell, G.
    Kalkum, G.
    Kampmann, C.
    Beck, M.
    CLINICAL GENETICS, 2012, 81 (05) : 485 - 490
  • [43] Ambulatory enzyme replacement therapy and clinical evaluation in Fabry's disease
    Breunig, F
    Weidemann, F
    Strotmann, J
    Beer, M
    Krane, V
    Wanner, C
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 581 - 581
  • [44] Enzyme-replacement therapy in mucopolysaccharidosis I.
    Kakkis, ED
    Muenzer, J
    Tiller, GE
    Waber, L
    Belmont, J
    Passage, M
    Izykowski, B
    Phillips, J
    Doroshow, R
    Walot, I
    Hoft, R
    Yu, KT
    Okazaki, S
    Lewis, D
    Lachman, R
    Thompson, JN
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03): : 182 - 188
  • [45] Shortened PR intervals and cardiac glycolipid levels respond to enzyme replacement therapy in Fabry disease
    Lee, P
    Germain, DP
    Eng, CM
    Guffon, N
    Wilcox, WR
    Waldek, S
    Caplan, L
    Grek, V
    Tummers, R
    Desnick, RJ
    CIRCULATION, 2002, 106 (16) : E103 - E103
  • [46] Immune response to enzyme replacement therapy in Fabry disease: Impact on clinical outcome?
    Hollak, C. E. M.
    Linthorst, G. E.
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (01) : 1 - 3
  • [47] Enzyme-replacement therapy for metabolic storage disorders
    Brady, RO
    Schiffmann, R
    LANCET NEUROLOGY, 2004, 3 (12): : 752 - 756
  • [48] Response of rapidly progressive Fabry disease nephropathy in a female to enzyme replacement therapy
    West, M
    Geldenhuys, L
    Lemoine, K
    ACTA PAEDIATRICA, 2006, 95 : 134 - 134
  • [49] Cardiomyopathy and Response to Enzyme Replacement Therapy in a Male Mouse Model for Fabry Disease
    Cat, Aurelie Nguyen Dinh
    Escoubet, Brigitte
    Agrapart, Vincent
    Griol-Charhbili, Violaine
    Schoeb, Trenton
    Feng, Wenguang
    Jaimes, Edgar
    Warnock, David G.
    Jaisser, Frederic
    PLOS ONE, 2012, 7 (05):
  • [50] Enzyme-Replacement Therapy in Life-Threatening Hypophosphatasia
    Whyte, Michael P.
    Greenberg, Cheryl R.
    Salman, Nada J.
    Bober, Michael B.
    McAlister, William H.
    Wenkert, Deborah
    Van Sickle, Bradley J.
    Simmons, Jill H.
    Edgar, Terence S.
    Bauer, Martin L.
    Hamdan, Mohamed A.
    Bishop, Nick
    Lutz, Richard E.
    McGinn, Mairead
    Craig, Stanley
    Moore, Jean N.
    Taylor, John W.
    Cleveland, Robert H.
    Cranley, William R.
    Lim, Ruth
    Thacher, Tom D.
    Mayhew, Jill E.
    Downs, Matthew
    Millan, Jose Luis
    Skrinar, Alison M.
    Crine, Philippe
    Landy, Hal
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 904 - 913
12345